Coca-Cola downplays weight-loss drug fears as it raises revenue forecast - Financial Times
- Coca-Cola downplays weight-loss drug fears as it raises revenue forecast Financial Times
- Coca-Cola beats earnings estimates, raises outlook as volume grows despite price hikes CNBC
- Wait for Coke to Go Flat Before Buying More RealMoney
- Coca-Cola Non-GAAP EPS of $0.74 beats by $0.05, revenue of $12B beats by $580M (NYSE:KO) Seeking Alpha
- Coca-Cola CEO: Marketing acts as a 'motor' to drive financial results Marketing Week
- View Full Coverage on Google News